Eurofins Scientific : Managers' transactions PDMRs acceptance of grant of stock options under a LTI programme

February 03, 2023 at 06:51 am EST

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL

RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1. Details of the person discharging managerial responsibilities/person closely associated

a)	Name1	François VIGNEAU

2.	Reason for the notification
a)	Position / status2	Member of the Group Operating Council
b)	Initial notification / amendment3	Initial

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)	Name4	Eurofins Scientific S.E.
b)	LEI5	529900JEHFM47DYY3S57

	Details of the transaction(s)
	section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)
4.	each place where transactions have been conducted
	Description of the financial
a)	instrument, type of instrument 6	Share
	Identification code7	ISIN: FR0014000MR3
		Acceptance of grant of stock options under a LTI programme
b)	Nature of the transaction8
Transaction is linked to the Eurofins stock option / free share / stock option program
		Price(s)	Volume(s)
c)	Price(s) and volume(s)9	n/a	5,559 options
	Aggregated information
	- Aggregated volume10
d)	- Price11
e)	Date of the transaction12	2023-01-31
f)	Place of the transaction13	n/a

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL

RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1. Details of the person discharging managerial responsibilities/person closely associated

a)	Name1	Beth Di Paolo

2.	Reason for the notification
a)	Position / status2	Member of the Group Operating Council
b)	Initial notification / amendment3	Initial

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)	Name4	Eurofins Scientific S.E.
b)	LEI5	529900JEHFM47DYY3S57

	Details of the transaction(s)
	section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)
4.	each place where transactions have been conducted
	Description of the financial
a)	instrument, type of instrument 6	Share
	Identification code7	ISIN: FR0014000MR3
		Acceptance of grant of stock options under a LTI programme
b)	Nature of the transaction8
Transaction is linked to the Eurofins stock option / free share / stock option program
		Price(s)	Volume(s)
c)	Price(s) and volume(s)9	n/a	9,584 options
	Aggregated information
	- Aggregated volume10
d)	- Price11
e)	Date of the transaction12	2023-01-31
f)	Place of the transaction13	n/a

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL

RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1. Details of the person discharging managerial responsibilities/person closely associated

a)	Name1	Yvoine Remy

2.	Reason for the notification
a)	Position / status2	Member of the Group Operating Council
b)	Initial notification / amendment3	Initial

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)	Name4	Eurofins Scientific S.E.
b)	LEI5	529900JEHFM47DYY3S57

	Details of the transaction(s)
	section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)
4.	each place where transactions have been conducted
	Description of the financial
a)	instrument, type of instrument 6	Share
	Identification code7	ISIN: FR0014000MR3
		Acceptance of grant of stock options under a LTI programme
b)	Nature of the transaction8
Transaction is linked to the Eurofins stock option / free share / stock option program
		Price(s)	Volume(s)
c)	Price(s) and volume(s)9	n/a	19,175 options
	Aggregated information
	- Aggregated volume10
d)	- Price11
e)	Date of the transaction12	2023-01-31
f)	Place of the transaction13	n/a

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL

RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1. Details of the person discharging managerial responsibilities/person closely associated

a)	Name1	Gabriel Julia

2.	Reason for the notification
a)	Position / status2	Member of the Group Operating Council
b)	Initial notification / amendment3	Initial

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)	Name4	Eurofins Scientific S.E.
b)	LEI5	529900JEHFM47DYY3S57

	Details of the transaction(s)
	section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)
4.	each place where transactions have been conducted
	Description of the financial
a)	instrument, type of instrument 6	Share
	Identification code7	ISIN: FR0014000MR3
		Acceptance of grant of stock options under a LTI programme
b)	Nature of the transaction8
Transaction is linked to the Eurofins stock option / free share / stock option program
		Price(s)	Volume(s)
c)	Price(s) and volume(s)9	n/a	9,949 options
	Aggregated information
	- Aggregated volume10
d)	- Price11
e)	Date of the transaction12	2023-01-31
f)	Place of the transaction13	n/a

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL

RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1. Details of the person discharging managerial responsibilities/person closely associated

a)	Name1	Laurent Lebras

2.	Reason for the notification
a)	Position / status2	Member of the Group Operating Council
b)	Initial notification / amendment3	Initial

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)	Name4	Eurofins Scientific S.E.
b)	LEI5	529900JEHFM47DYY3S57

	Details of the transaction(s)
	section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)
4.	each place where transactions have been conducted
	Description of the financial
a)	instrument, type of instrument 6	Share
	Identification code7	ISIN: FR0014000MR3
		Acceptance of grant of stock options under a LTI programme
b)	Nature of the transaction8
Transaction is linked to the Eurofins stock option / free share / stock option program
		Price(s)	Volume(s)
c)	Price(s) and volume(s)9	n/a	20,700 options
	Aggregated information
	- Aggregated volume10
d)	- Price11
e)	Date of the transaction12	2023-01-31
f)	Place of the transaction13	n/a

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

Original Link
Original Document
Permalink

Disclaimer

Eurofins Scientific SE published this content on 03 February 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 February 2023 11:48:05 UTC.

	1st Jan change	Capi.
EUROFINS SCIENTIFIC SE	+4.44%	12.37B
CVS HEALTH CORPORATION	-13.25%	87.77B
HCA HEALTHCARE, INC.	+18.01%	82.08B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+11.97%	30.03B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-8.50%	17.08B
FRESENIUS SE & CO. KGAA	-1.46%	16.41B
FRESENIUS MEDICAL CARE AG	+5.11%	12.17B
PURE HEALTH HOLDING	-31.05%	11.89B
DAVITA INC.	+27.83%	11.62B
UNIVERSAL HEALTH SERVICES, INC.	+8.18%	10.85B

1st Jan change

Capi.

EUROFINS SCIENTIFIC SE

+4.44%

12.37B

CVS HEALTH CORPORATION

-13.25%

87.77B

HCA HEALTHCARE, INC.

+18.01%

82.08B

DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY

+11.97%

30.03B

LABORATORY CORPORATION OF AMERICA HOLDINGS

-8.50%

17.08B

FRESENIUS SE & CO. KGAA

-1.46%

16.41B

FRESENIUS MEDICAL CARE AG

+5.11%

12.17B

PURE HEALTH HOLDING

-31.05%

11.89B

DAVITA INC.

+27.83%

11.62B

UNIVERSAL HEALTH SERVICES, INC.

+8.18%

10.85B

Market Closed - Euronext Paris Other stock markets 11:37:29 2024-04-23 am EDT			After market 03:59:56 pm
61.6 ^EUR	+2.19%		60.49	-1.80%

05:58pm	CAC40: up sharply, back over 8100 pts	CF
Apr. 05	CAC40: week ends at half-mast, gold at its zenith	CF

CAC40: up sharply, back over 8100 pts	11:58am	CF
CAC40: week ends at half-mast, gold at its zenith	Apr. 05	CF
CAC40: pullback reduced, WStreet +0.7%, Brent at $91, Gold at $233	Apr. 05	CF
CAC40: easily preserves 8,000Pts, NFP has no impact	Apr. 05	CF
CAC40: ends the day balanced after a salvo of statistics	Apr. 04	CF
CAC40: frozen at 8,155, W-Street well disposed, gold at its zenith	Apr. 04	CF
CAC40: indecisive towards 8,160, W-Street climbs back to the top	Apr. 04	CF
EUROFINS SCIENTIFIC : Berenberg raises its price target	Apr. 04	CF
CAC40: up slightly after PMI figures	Apr. 04	CF
Eurofins Scientific to Purchase US-based Ascend Clinical	Apr. 03	MT
Eurofins completes acquisition of Ascend Clinical	Apr. 03	CF
Eurofins Scientific SE acquired Ascend Clinical, LLC.	Apr. 02	CI
CAC40: ends with a balanced performance, helped by the banking sector	Mar. 28	CF
CAC40: all-time high, tackles 8250 resistance level	Mar. 28	CF
European Equities Close Mixed in Monday Trading; Real Estate, Pharmaceutical Stocks Rise	Mar. 11	MT
CAC40: insignificant decline in limited volumes	Mar. 11	CF
Enzymatica Obtains CE Marking for ColdZyme Mouth Spray	Mar. 11	MT
CAC40: zero reaction to US PCE, but February ends on a high note	Feb. 29	CF
CAC40: steady ahead of US inflation figures	Feb. 29	CF
CAC40: frozen at 7.945, heavy sanction on Teleperformance	Feb. 28	CF
CAC40: remains stable despite Teleperformance's fall	Feb. 28	CF
EUROFINS SCIENTIFIC : Lackluster FCF and dividend cut weigh on the share price	Feb. 28
CAC40: up slightly, driven by Bouygues and Alstom	Feb. 27	CF
CAC40: approaches 8,000, Nasdaq solid despite US stats	Feb. 27	CF
CAC40: back above 7,950, tech supports Wall-Street	Feb. 27	CF

Eurofins Scientific SE

Equities

ERF

FR0014000MR3

Healthcare Facilities & Services

Eurofins Scientific : Managers' transactions PDMRs acceptance of grant of stock options under a LTI programme

Latest news about Eurofins Scientific SE

Chart Eurofins Scientific SE

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Eurofins Scientific SE

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Other Healthcare Facilities & Services